(Q47218999)

12 January 2018

title

Low-level HIV replication in mixed glial cultures is associated with alterations in the processing of p55(Gag). (English)

1 reference

12 January 2018

author name string

Andrew V Albright

series ordinal

1

1 reference

12 January 2018

Robin M Vos

series ordinal

2

1 reference

12 January 2018

Francisco González-Scarano

series ordinal

3

1 reference

12 January 2018

language of work or name

English

0 references

publication date

1 August 2004

1 reference

12 January 2018

published in

Virology

1 reference

12 January 2018

volume

325

1 reference

12 January 2018

issue

2

1 reference

12 January 2018

page(s)

328-339

1 reference

12 January 2018

HIV-1 infection of cultured human adult oligodendrocytes

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Efavirenz is a potent nonnucleoside reverse transcriptase inhibitor of HIV type 1 replication in microglia in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Cellular reservoirs of HIV-1 in the central nervous system of infected individuals: identification by the combination of in situ polymerase chain reaction and immunohistochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Therapeutic targeting of human immunodeficiency virus type-1 latency: current clinical realities and future scientific possibilities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

A national tissue bank to track HIV eradication and immune reconstruction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Correlates of independent HIV-1 replication in the CNS and of its control by antiretrovirals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

The late domain of human immunodeficiency virus type 1 p6 promotes virus release in a cell type-dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

In patients on prolonged HAART, a significant pool of HIV infected CD4 T cells are HIV-specific.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Changes to AIDS dementia complex in the era of highly active antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

HIV-1 infection of non-dividing cells: evidence that the amino-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

The role of mononuclear phagocytes in HTLV-III/LAV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

HIV reproducibly establishes a latent infection after acute infection of T cells in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Pathways to neuronal injury and apoptosis in HIV-associated dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

The role of monocytes and macrophages in the pathogenesis of HIV-1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Detection of AIDS virus in macrophages in brain tissue from AIDS patients with encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Reservoirs of HIV infection or carriage: monocytic, dendritic, follicular dendritic, and B cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Turnover of resident microglia in the normal adult mouse brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

HIV-1 in human alveolar macrophages from infected patients is latent in vivo but replicates after in vitro stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Low infection frequency of macrophages in the spleens of HIV+ patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Activation of infectious virus from latent human immunodeficiency virus infection of monocytes in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Human macrophage activation programs induced by bacterial pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Cell-type-dependent targeting of human immunodeficiency virus type 1 assembly to the plasma membrane and the multivesicular body

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Infectious HIV-1 assembles in late endosomes in primary macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Decay characteristics of HIV-1-infected compartments during combination therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Isolation of HIV-1 from monocytes but not T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Diversity of acetylation targets and roles in transcriptional regulation: the human immunodeficiency virus type 1 promoter as a model system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Human macrophages accumulate HIV-1 particles in MHC II compartments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Influence of cell cycle on HIV-1 expression differs among various models of chronic infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Simian immunodeficiency virus encephalitis: analysis of envelope sequences from individual brain multinucleated giant cells and tissue samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

HIV-associated cognitive impairment before and after the advent of combination therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

HIV-1 integration in the human genome favors active genes and local hotspots

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

GM-CSF and M-CSF modulate beta-chemokine and HIV-1 expression in microglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Relationship between load of virus in alveolar macrophages from human immunodeficiency virus type 1-infected persons, production of cytokines, and clinical status.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Monocytes harbour replication-competent, non-latent HIV-1 in patients on highly active antiretroviral therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

A role for ubiquitin ligase recruitment in retrovirus release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Cytokine expression in the brain during the acquired immunodeficiency syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Specific tropism of HIV-1 for microglial cells in primary human brain cultures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Viral dynamics in human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Intracerebral cytokine messenger RNA expression in acquired immunodeficiency syndrome dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

inferred from DOI database lookup

7 January 2021

based on heuristic

Role of the mononuclear phagocyte system in the development of acquired immunodeficiency syndrome (AIDS).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

inferred from DOI database lookup

7 January 2021

based on heuristic

Human immunodeficiency virus type 1 T-lymphotropic strains enter macrophages via a CD4- and CXCR4-mediated pathway: replication is restricted at a postentry level

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.04.028

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2004.04.028

1 reference

12 January 2018

1 reference

12 January 2018